Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dapagliflozin Adverse Reaction”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 94
Post-approval studies (Phase 4)UnknownNCT05717257
What this trial is testing

Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE)

Who this might be right for
Dapagliflozin Adverse ReactionEfficacySystemic Right Ventricle
Monaldi Hospital 50
Post-approval studies (Phase 4)Active Not RecruitingNCT06000462
What this trial is testing

The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes

Who this might be right for
ObesityDapagliflozin Adverse ReactionWeight Loss+1 more
Oman Ministry of Health 150
Testing effectiveness (Phase 2)UnknownNCT06341842
What this trial is testing

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

Who this might be right for
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 316